Tremfya 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9W48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,008
Award facts
- Contract value 100% obligated
- $13,008.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,008.22 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Tremfya 100 mg/ml syringes, with an ultimate completion date of January 13, 2026. This is a firm fixed-price contract with no set-aside designation, competed on a full and open basis. The place of performance is the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Tremfya (guselkumab) is an immunosuppressive medication used in the treatment of plaque psoriasis and other immune-mediated conditions. This delivery order represents a routine pharmaceutical procurement through the DLA Medical Supply Chain to support military treatment facilities and federal healthcare systems. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability as a critical vendor for military and veteran healthcare procurement, with consistent delivery of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9W48?
SPE2DR26F9W48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9W48 worth?
The government has obligated $13,008 on SPE2DR26F9W48.
Is contract SPE2DR26F9W48 an order under another contract?
Yes. SPE2DR26F9W48 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W48 competed?
The extent of competition for SPE2DR26F9W48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award